academic article

• Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age..  Early human development.  128:69-76. 2019
• Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age..  Early human development.  128:69-76. 2019
• Role of caregiver-reported outcomes in identification of children with prenatal alcohol exposure during the first year of life..  Pediatric research.  84:362-370. 2018
• SPIRIT trial: A phase III pragmatic trial of an advance care planning intervention in ESRD..  Contemporary clinical trials.  64:188-194. 2018
• Barriers and facilitators to dispensing of intranasal naloxone by pharmacists. 2018
• Hypersynchrony in MEG spectral amplitude in prospectively-identified 6-month-old infants prenatally exposed to alcohol..  NeuroImage. Clinical.  17:826-834. 2018
• Hypersynchrony in MEG spectral amplitude in prospectively-identified 6-month-old infants prenatally exposed to alcohol..  NeuroImage. Clinical.  17:826-834. 2018
• Hepatitis C Cascade of Care Among Pregnant Women on Opioid Agonist Pharmacotherapy Attending a Comprehensive Prenatal Program..  Maternal and child health journal.  21:1778-1783. 2017
• The Validity of Phosphatidylethanol in Dried Blood Spots of Newborns for the Identification of Prenatal Alcohol Exposure..  Alcoholism, clinical and experimental research.  :-. 2014
• Sources of potential lead exposure among pregnant women in New Mexico. 2013
• The feasibility and cost of neonatal screening for prenatal alcohol exposure by measuring phosphatidylethanol in dried blood spots..  Alcoholism, clinical and experimental research.  37:1008-1015. 2013
• Advanced gestational age increases serum carbohydrate-deficient transferrin levels in abstinent pregnant women..  Alcohol and alcoholism (Oxford, Oxfordshire).  47:683-687.